Annual Long Term Debt
$7.36 M
-$6.69 M-47.60%
31 December 2023
Summary:
Cue Biopharma annual long term debt is currently $7.36 million, with the most recent change of -$6.69 million (-47.60%) on 31 December 2023. During the last 3 years, it has risen by +$5.00 million (+210.87%). CUE annual long term debt is now -47.60% below its all-time high of $14.05 million, reached on 31 December 2022.CUE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.65 M
-$1.59 M-37.52%
30 September 2024
Summary:
Cue Biopharma quarterly long term debt is currently $2.65 million, with the most recent change of -$1.59 million (-37.52%) on 30 September 2024. Over the past year, it has dropped by -$6.36 million (-70.56%). CUE quarterly long term debt is now -84.08% below its all-time high of $16.67 million, reached on 30 June 2022.CUE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.6% | -70.6% |
| 3 y3 years | +210.9% | +100.0% |
| 5 y5 years | +100.0% | +1.7% |
CUE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.6% | +210.9% | -84.1% | |
| 5 y | 5 years | -47.6% | -84.1% | ||
| alltime | all time | -47.6% | -84.1% |
Cue Biopharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.65 M(-37.5%) |
| June 2024 | - | $4.25 M(-27.0%) |
| Mar 2024 | - | $5.82 M(-20.9%) |
| Dec 2023 | $7.36 M(-47.6%) | $7.36 M(-18.3%) |
| Sept 2023 | - | $9.02 M(-15.9%) |
| June 2023 | - | $10.72 M(-13.7%) |
| Mar 2023 | - | $12.41 M(-11.7%) |
| Dec 2022 | $14.05 M(+174.4%) | $14.05 M(-8.2%) |
| Sept 2022 | - | $15.31 M(-8.1%) |
| June 2022 | - | $16.67 M(+14.0%) |
| Mar 2022 | - | $14.62 M(+185.5%) |
| Dec 2021 | $5.12 M | $5.12 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $1.08 M(-54.2%) |
| Dec 2020 | $2.37 M(+75.7%) | $2.37 M(-34.8%) |
| Sept 2020 | - | $3.63 M(-13.1%) |
| June 2020 | - | $4.18 M(+2055.7%) |
| Mar 2020 | - | $194.00 K(-85.6%) |
| Dec 2019 | $1.35 M(>+9900.0%) | $1.35 M(-48.4%) |
| Sept 2019 | - | $2.61 M(-31.1%) |
| June 2019 | - | $3.79 M(-23.4%) |
| Mar 2019 | - | $4.95 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cue Biopharma annual long term debt?
- What is the all time high annual long term debt for Cue Biopharma?
- What is Cue Biopharma annual long term debt year-on-year change?
- What is Cue Biopharma quarterly long term debt?
- What is the all time high quarterly long term debt for Cue Biopharma?
- What is Cue Biopharma quarterly long term debt year-on-year change?
What is Cue Biopharma annual long term debt?
The current annual long term debt of CUE is $7.36 M
What is the all time high annual long term debt for Cue Biopharma?
Cue Biopharma all-time high annual long term debt is $14.05 M
What is Cue Biopharma annual long term debt year-on-year change?
Over the past year, CUE annual long term debt has changed by -$6.69 M (-47.60%)
What is Cue Biopharma quarterly long term debt?
The current quarterly long term debt of CUE is $2.65 M
What is the all time high quarterly long term debt for Cue Biopharma?
Cue Biopharma all-time high quarterly long term debt is $16.67 M
What is Cue Biopharma quarterly long term debt year-on-year change?
Over the past year, CUE quarterly long term debt has changed by -$6.36 M (-70.56%)